The degree of uPAR expression in prostate cancer specimens is associated with important clinicopathological prognostic features, such as pathological tumor stage, Gleason score, positive surgical margins, and shorter biochemical recurrence free survival [11,12]. This evidence concerns the gene PLAUR and prostate cancer.